Skip to content
Screener

PP&E (Net) at other companies

Medtronic logo
MedtronicMDT
$7.42B+8.5%
LivaNova logo
LivaNovaLIVN
$273.34M+39.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$2.91M+33.5%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$100.69M+30.5%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$2.34M-26.3%
CVRx, Inc. logo
CVRx, Inc.CVRX
$2.06M-12.1%

Other financials

Income statement

See full
Revenue$22.8M+17.1%
Gross profit$18.9M+16.6%
Operating income-$5.1M+37.2%
Net income-$6.2M+28.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$12.8M-44.4%
Total debt$69.9M-2.2%
Total equity$11.9M-38.9%
Total assets$97.0M-8.6%

Cash flow

See full
Operating cash flow-$3.9M-87.1%
CapEx$125.0K-25.6%
Free cash flow-$4.0M-78.7%

Valuation

See full
Market cap$507.31M+74.0%
Enterprise value$564.47M+66.0%
P/S5.1×+1.7×

Profitability

See full
Gross margin79.6%+2.6pp
Operating margin-15.3%-4.3pp
Net margin-19.3%-5.2pp
FCF margin-12.2%-3.3pp

Returns & leverage

See full
Return on equity-122.1%-28.9pp
Debt / equity5.9×+2.2×
Current ratio4.9×-0.5×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:33 PM EDT
Fiscal quarter
Q4 FY2030
Calendar quarter
Q4 2030
Accession
0001528287-26-000030
(in thousands, except for share and per share amounts)June 30, 2026December 31, 2025
Prepaid expenses and other current assets1,4531,438
Current assets of discontinued operations3,779
Total current assets86,19394,073
Property and equipment, net1,2431,125
Operating lease right-of-use asset9,21610,132
Restricted cash241122
Other assets98113
Total assets$96,991$105,565

Item 1. Financial Statements (Unaudited)

FAQ

What is Neuropace, Inc.'s PP&E (net)?
Neuropace, Inc. (NPCE) reported PP&E (net) of $1.24M in Q2 2026.
How has Neuropace, Inc.'s PP&E (net) changed year-over-year?
Neuropace, Inc.'s PP&E (net) increased by 7.5% year-over-year, from $1.16M to $1.24M.
What is the long-term trend for Neuropace, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Neuropace, Inc.'s PP&E (net) has grown at a 16.9% compound annual growth rate (CAGR), from $515K to $1.13M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Neuropace, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude